(212)Pb-Labeled Antibody 225.28 Targeted to Chondroitin Sulfate Proteoglycan 4 for Triple-Negative Breast Cancer Therapy in Mouse Models

Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer with a poor prognosis. There is a clinical need for effective, targeted therapy strategies that destroy both differentiated TNBC cells and TNBC cancer initiating cells (CICs), as the latter are implicated in the metastasi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasten, Benjamin B., Oliver, Patsy G., Kim, Harrison, Fan, Jinda, Ferrone, Soldano, Zinn, Kurt R., Buchsbaum, Donald J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979285/
https://www.ncbi.nlm.nih.gov/pubmed/29561763
http://dx.doi.org/10.3390/ijms19040925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979285/
https://www.ncbi.nlm.nih.gov/pubmed/29561763
http://dx.doi.org/10.3390/ijms19040925

Ejemplares similares